Search

Your search keyword '"Ko, YJ"' showing total 555 results

Search Constraints

Start Over You searched for: Author "Ko, YJ" Remove constraint Author: "Ko, YJ"
555 results on '"Ko, YJ"'

Search Results

1. Searching for low-mass dark matter via the Migdal effect in COSINE-100

2. Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database

3. Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab

4. Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database

5. Analysis of the attachment and differentiation of three-dimensional rotary wall vessel cultured human preosteoblasts on dental implant surfaces.

6. A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma

7. Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

11. Searching for low-mass dark matter via Migdal effect in COSINE-100 [preprint]

12. Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy for Urothelial Carcinoma

13. Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design

14. Patient Eligibility and Trial Design for the Salvage Therapy of Advanced Urothelial Carcinoma

15. Strategy for Enhancing Catalytic Active Site: Introduction of 1D material InSeI for Electrochemical CO 2 Reduction to Formate.

16. Nostoxanthin Biosynthesis by Sphingomonas Species (COS14-R2): Isolation, Identification, and Optimization of Culture Conditions.

17. Abnormal Electroencephalogram Findings and Its Correlation With Clinical Features From Pediatric Patients in Psychiatric Clinic.

18. Examining the Relationship Between Polystyrene Microplastics and Male Fertility: Insights From an In Vivo Study and In Vitro Sertoli Cell Culture.

19. 3D-Printed proangiogenic patches of photo-crosslinked gelatin and polyurethane hydrogels laden with vascular cells for treating vascular ischemic diseases.

20. Enhancing polyethylene degradation: a novel bioprocess approach using Acinetobacter nosocomialis pseudo-resting cells.

21. Dual-Action Protein-siRNA Conjugates for Targeted Disruption of CD47-Signal Regulatory Protein α Axis in Cancer Therapy.

22. Novel Flowable Hemostatic Agent ActiClot: Efficacy and Safety Assessment in Rat and Porcine Models.

23. Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada.

24. Exploring Oxygen Vacancy Effect in 1D Structural SnIP for CO 2 Electro-Reduction to Formate.

25. Application of a machine learning and optimization method to predict patellofemoral instability risk factors in children and adolescents.

26. Biotransformation of docosahexaenoic acid into 10R,17S-dihydroxydocosahexaenoic acid as protectin DX 10-epimer by serial reactions of arachidonate 8R- and 15S-lipoxygenases.

27. Discovery of Terminal Oxazole-Bearing Natural Products by a Targeted Metabologenomic Approach.

28. Bioproduction of porphyrins, phycobilins, and their proteins using microbial cell factories: engineering, metabolic regulations, challenges, and perspectives.

29. Extrinsic hydrophobicity-controlled silver nanoparticles as efficient and stable catalysts for CO 2 electrolysis.

30. 2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.

31. Calcium Chloride as a Novel Stabilizer for Foot-and-Mouth Disease Virus and Its Application in the Vaccine Formulation.

32. Overproduction of Xanthophyll Pigment in Flavobacterium sp. JSWR-1 under Optimized Culture Conditions.

33. Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor.

34. Chaenomelin, a New Phenolic Glycoside, and Anti- Helicobacter pylori Phenolic Compounds from the Leaves of Salix chaenomeloides .

35. Calcium Chloride Treatment Enhances Antigen Production in Foot-and-Mouth Disease Vaccines for Serotypes SAT1 and SAT3.

36. Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics.

37. A cognitive-behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trial.

38. An LGR4 agonist activates the GSK‑3β pathway to inhibit RANK‑RANKL signaling during osteoclastogenesis in bone marrow‑derived macrophages.

39. Comparison of specificity and sensitivity of diagnostic methods for Enteromyxum leei and Enteromyxum fugu detected from cultured tiger puffer, Takifugu rubripes in Korea.

40. Familial focal segmental glomerulosclerosis associated with a WT1 gene missense mutation: A case report.

41. Hollow Ru/RuO 2 nanospheres with nanoparticulate shells for high performance electrocatalytic oxygen evolution reactions.

42. Anatomical location of motor branch points in the flexor digitorum superficialis for the injection site of botulinum toxin.

43. Antiviral Effects of Secondary Metabolites from Jatropha podagrica Leaves against the Pseudotyped Virus of SARS-CoV-2 Omicron.

44. Search for Boosted Dark Matter in COSINE-100.

45. Development and Validation of a Clinical Practicum Transition Shock Scale (CPT-Shock) for Korean Nursing Students.

46. Targeted and Logical Discovery of Piperazic Acid-Bearing Natural Products Based on Genomic and Spectroscopic Signatures.

47. Production of a New Biosurfactant by a New Yeast Species Isolated from Prunus mume Sieb. et Zucc.

48. Epilepsy phenotype and gene ontology analysis of the 129 genes in a large neurodevelopmental disorders cohort.

49. Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea.

50. Production of Foot-and-Mouth Disease Type O and A Vaccine Antigens on a Pilot Scale and Determination of Optimal Amount of Antigen for Monovalent Vaccines.

Catalog

Books, media, physical & digital resources